A new drug for migraine prophylaxis is being trialled in group of 100 women who suffer with migraines to see whether it can reduce the frequency of their migraines over the next 6 months. A similar group of women who are newly started on Propranolol are also followed up for 6 months to see how frequent they have migraines whilst on the prophylactic treatment.
What type of study is this?
